Tobias Deuse
5Patents
1h-index
1Co-inventors
33Inventor score
Filing activity: Apr 20, 2015 → Jun 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11162079B2 | Blood type O Rh-hypo-immunogenic pluripotent cells | Emerging Cross-Sectional Technologies | 3 | Active |
| US9480666B2 | Compositions and methods for inhibiting intimal hyperplasia | Human Necessities | 1 | Active |
| US10016378B2 | Compositions and methods for inhibiting intimal hyperplasia | Human Necessities | 0 | Active |
| US12391923B2 | SIRPα-silenced natural killer (NK) cells | Chemistry; Metallurgy | 0 | Active |
| US12221622B2 | Modified pluripotent cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.